Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Jonathan Sheena | Director | 2025-07-02 | 208 | $161.23 | $33.54kSell |
Jonathan Sheena | Director | 2025-07-02 | 300 | $159.14 | $47.74kSell |
Jonathan Sheena | Director | 2025-07-02 | 1,011 | $160.11 | $161.87kSell |
Jonathan Sheena | Director | 2025-07-02 | 189 | $161.29 | $30.48kSell |
Jonathan Sheena | Director | 2025-07-02 | 200 | $159.23 | $31.85kSell |
Jonathan Sheena | Director | 2025-07-02 | 1,092 | $160.11 | $174.83kSell |
Steven Leonard Chapman | CEO AND PRESIDENT | 2025-07-01 | 648 | $167.77 | $108.71kSell |
Solomon Moshkevich | PRESIDENT CLINICALDIAGNOSTICS | 2025-07-01 | 2,109 | $167.25 | $352.73kSell |
Solomon Moshkevich | PRESIDENT CLINICALDIAGNOSTICS | 2025-07-01 | 291 | $167.79 | $48.83kSell |
Gail Boxer Marcus | Director | 2025-07-01 | 4,299 | $24.42 | $104.98kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Vanguard Group Inc | 9.08% | 12,393,827 | $1.99B | Institution |
Price T Rowe Associates Inc | 7.72% | 10,537,743 | $1.69B | Institution |
Blackrock Inc | 7.65% | 10,440,588 | $1.67B | Institution |
Jpmorgan Chase Co | 5.39% | 7,361,963 | $1.18B | Institution |
Claremont Creek Ventures L P | 4.29% | 5,864,630 | $940.86M | Insider |
Roelof Botha | 4.16% | 5,683,747 | $911.84M | Insider |
Sc XII Management LLC | 3.97% | 5,421,122 | $869.71M | Insider |
Matthew Rabinowitz | 3.60% | 4,916,138 | $788.70M | Insider |
James Healy | 3.44% | 4,697,100 | $753.56M | Insider |
Farallon Capital Management LLC | 3.33% | 4,547,809 | $729.60M | Institution |